These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24739600)

  • 1. Matters of controversy regarding lipid therapy for Japanese patients with coronary artery disease.
    Komiyama M; Wada H; Hasegawa K
    Intern Med; 2014; 53(8):817-8. PubMed ID: 24739600
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of multiple antilipidemic agents on Vertical Auto Profile II guided treatment of dyslipoproteinemia.
    Rembold CM; Fan R; Rembold KE; Ayers CR
    Am J Cardiol; 2002 Oct; 90(8):887-90. PubMed ID: 12372582
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein(a) and coronary artery disease: ongoing debate.
    Celik T; Yuksel C; Iyisoy A; Isik E
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):e33-4. PubMed ID: 18472410
    [No Abstract]   [Full Text] [Related]  

  • 4. Shifting views on lipid lowering therapy.
    Krumholz HM; Hayward RA
    BMJ; 2010 Jul; 341():c3531. PubMed ID: 20667950
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of coronary atherosclerosis.
    Hodis HN; Cashin-Hemphill L; Mack WJ
    Heart Dis Stroke; 1994; 3(4):182-7. PubMed ID: 7921660
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice.
    Dänschel W; Steinhagen-Thiessen E; Buffleben C; Pittrow D; Hildemann SK
    Curr Med Res Opin; 2013 Jan; 29(1):33-40. PubMed ID: 23157464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lowering LDL cholesterol. How much is enough?].
    März W; Grammer TB
    Internist (Berl); 2007 Mar; 48(3):319-26. PubMed ID: 17333056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid control in patients with coronary artery disease in a healthcare area in Cáceres (Spain): LIPICERES study].
    Gómez-Barrado JJ; Ortiz C; Gómez-Turégano M; Gómez-Turégano P; Garcipérez-de-Vargas FJ; Sánchez-Calderón P
    Clin Investig Arterioscler; 2017; 29(1):13-19. PubMed ID: 28062171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiographic evidence that treatment of lipoprotein abnormalities prevents progression of coronary atherosclerosis.
    Olsson AG
    Eur Heart J; 1987 Aug; 8 Suppl E():55-8. PubMed ID: 3315678
    [No Abstract]   [Full Text] [Related]  

  • 11. Focus on HDL as a therapeutic target for CAD risk reduction.
    Davidson MH
    Am J Cardiol; 2009 Nov; 104(10 Suppl):1E-2E. PubMed ID: 19895937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Editorial comment: lipoprotein (a) and coronary artery disease].
    Soydan I
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):264-5. PubMed ID: 12803215
    [No Abstract]   [Full Text] [Related]  

  • 13. [Association of microalbuminuria and fasting insulin levels with presence and severity of coronary artery disease in non-diabetic cases].
    Ekicibaşi E; Kaderli AA; Kazazoğlu AR; Ozdemir B
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):16-21. PubMed ID: 18258528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of small dense LDL with a coronary artery disease and diabetes in urban Asian Indians--the Chennai urban Asian Indians--The Chennai Urban Rural Epidemiology Study (CURES 8).
    Jadhav UM
    J Assoc Physicians India; 2005 May; 53():492-3; author reply 493. PubMed ID: 16124365
    [No Abstract]   [Full Text] [Related]  

  • 15. Atherogenic dyslipidemia in patients with established coronary artery disease.
    Lahoz C; Mostaza JM; Tranche S; Martin-Jadraque R; Mantilla MT; López-Rodriguez I; Monteiro B; Sanchez-Zamorano MA; Taboada M
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):103-8. PubMed ID: 20675108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia and coronary heart disease.
    Jones JD; Chambliss ML
    Arch Fam Med; 2000 Feb; 9(2):189-90. PubMed ID: 10693737
    [No Abstract]   [Full Text] [Related]  

  • 17. [HDL-cholesterol-- active or passive participant in the pathogenesis of atherosclerosis].
    Artenie R; Ungureanu D; Artenie A; Botnariu G; Anisie E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):282-7. PubMed ID: 14755929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report.
    Gotto AM
    Circulation; 2001 May; 103(17):2213-8. PubMed ID: 11331265
    [No Abstract]   [Full Text] [Related]  

  • 19. Progression and regression of atherosclerosis, what roles for LDL-cholesterol and HDL-cholesterol: a perspective.
    Barth JD; Arntzenius AC
    Eur Heart J; 1991 Aug; 12(8):952-7. PubMed ID: 1915434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attainment of low-density lipoprotein cholesterol goals in coronary artery disease.
    Kauffman AB; Olson KL; Youngblood ML; Zadvorny EB; Delate T; Merenich JA;
    J Clin Lipidol; 2010; 4(3):173-80. PubMed ID: 21122649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.